ATE251912T1 - Verwendung des erythropoietins zur behandlung von rheumatoider arthritis - Google Patents

Verwendung des erythropoietins zur behandlung von rheumatoider arthritis

Info

Publication number
ATE251912T1
ATE251912T1 AT95936127T AT95936127T ATE251912T1 AT E251912 T1 ATE251912 T1 AT E251912T1 AT 95936127 T AT95936127 T AT 95936127T AT 95936127 T AT95936127 T AT 95936127T AT E251912 T1 ATE251912 T1 AT E251912T1
Authority
AT
Austria
Prior art keywords
treatment
rheumatoid arthritis
erythropoietin
epo
seen
Prior art date
Application number
AT95936127T
Other languages
English (en)
Inventor
Anthonius Josef Gerardus Swaak
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE251912T1 publication Critical patent/ATE251912T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95936127T 1994-11-03 1995-10-26 Verwendung des erythropoietins zur behandlung von rheumatoider arthritis ATE251912T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203205 1994-11-03
PCT/NL1995/000370 WO1996014081A1 (en) 1994-11-03 1995-10-26 Use of erythropoietin in the treatment of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
ATE251912T1 true ATE251912T1 (de) 2003-11-15

Family

ID=8217342

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95936127T ATE251912T1 (de) 1994-11-03 1995-10-26 Verwendung des erythropoietins zur behandlung von rheumatoider arthritis

Country Status (9)

Country Link
US (2) US7344717B1 (de)
EP (1) EP0784480B1 (de)
AT (1) ATE251912T1 (de)
AU (1) AU3817495A (de)
DE (1) DE69531952T2 (de)
ES (1) ES2206521T3 (de)
IL (1) IL115826A (de)
WO (1) WO1996014081A1 (de)
ZA (1) ZA959325B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
DE19734293A1 (de) 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
DE60131393D1 (de) * 2000-05-02 2007-12-27 Action Pharma As Verfahren zur behandlung von erkrankungen assoziiert mit akuten entzündung unter nichtischämischen zustände
RU2197986C2 (ru) * 2001-03-23 2003-02-10 Волчек Игорь Анатольевич Иммуномодулирующее средство неинъекционного применения
DE10234192B4 (de) 2002-07-26 2009-11-26 Epoplus Gmbh Co.Kg Verwendung von Erythropoetin
RU2257216C2 (ru) * 2003-06-11 2005-07-27 Ханис Александр Юрьевич Иммуномодулирующее средство риботаб
US9610444B2 (en) 2013-03-15 2017-04-04 Pacesetter, Inc. Erythropoeitin production by electrical stimulation
EP4340865A4 (de) * 2021-05-18 2025-04-02 Attias, Eyal Verwendung von erythropoietin (epo) oder erythropoiesis stimulierendem mittel (esa) zur behandlung von osteomyelitis, knocheninfektion und knochenentzündung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732889A (en) 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
US5013718A (en) * 1986-11-21 1991-05-07 Amgen, Inc. Method for treating iron overload using EPO

Also Published As

Publication number Publication date
WO1996014081A1 (en) 1996-05-17
EP0784480A1 (de) 1997-07-23
ES2206521T3 (es) 2004-05-16
US7344717B1 (en) 2008-03-18
DE69531952D1 (de) 2003-11-20
EP0784480B1 (de) 2003-10-15
US9155782B2 (en) 2015-10-13
IL115826A0 (en) 1996-01-19
US20070249525A1 (en) 2007-10-25
DE69531952T2 (de) 2004-07-29
AU3817495A (en) 1996-05-31
IL115826A (en) 2000-07-26
ZA959325B (en) 1996-05-29

Similar Documents

Publication Publication Date Title
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
FI962557A0 (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ATE239474T1 (de) Verwendung von levobupivacain
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69631656D1 (de) Debromhymenialdisin und verwandte verbindungen zur behandlung von osteoarthritis
DE69531952D1 (de) Verwendung des erythropoietins zur behandlung von rheumatoider arthritis
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
DE68921229D1 (de) Prozess zur Behandlung von unlöslichem heterogenem Fusionsprotein.
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
NO972449L (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ATE227557T1 (de) Verwendung von zahnpflegemitteln enthaltend bovines kolostrum
DE69619051D1 (de) Behandlung von Füllstoffen mit Oxasilacycloalkanen
ATE218856T1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
EP0830057A4 (de) Verfahren zur inaktivierung von viralen und bakteriellen blutverunreinigungen
DE69736180D1 (de) Behandlung von manischen erkrankungen
FR2710539B1 (fr) Ensemble d'aiguille chirurgicale.
DE69734890D1 (de) Rdgb-proteine
DE59708511D1 (de) Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen
DE69721484D1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten
DE59609977D1 (de) Trapidil zur verwendung in der therapie von immunmodulatorisch beeinflussbaren krankheitsbildern

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0784480

Country of ref document: EP